Immuneering Corporation
IMRX
$3.95
-$0.08-1.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.87% | 8.21% | -7.63% | -10.81% | -14.03% |
| Total Depreciation and Amortization | -7.95% | -8.10% | -6.35% | -1.03% | 3.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.93% | -1.14% | 8.71% | 18.96% | 30.24% |
| Change in Net Operating Assets | -293.70% | 513.23% | 840.72% | 492.55% | 154.60% |
| Cash from Operations | 7.26% | 17.55% | 4.30% | -1.36% | -7.09% |
| Capital Expenditure | -278.01% | -67.29% | 88.76% | 91.38% | 83.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3,078.25% | -434.07% | -77.39% | -98.46% | -49.45% |
| Cash from Investing | -3,115.80% | -435.69% | -77.27% | -98.84% | -48.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,086.74% | 4,133.80% | 4,200.58% | 1,711.25% | -37.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,684.61% | -2,684.61% | -- | -- | 30.81% |
| Cash from Financing | 1,074.32% | 4,172.33% | 4,139.29% | 1,690.92% | -37.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 137.66% | 497.66% | 898.60% | 24.65% | -173.01% |